Monogram Orthopaedics, Inc.
MGRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 27% |
| R&D Expenses | $9 | $11 | $5 | $5 |
| G&A Expenses | $4 | $4 | $3 | $2 |
| SG&A Expenses | $7 | $7 | $6 | $5 |
| Sales & Mktg Exp. | $2 | $3 | $3 | $3 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $15 | $18 | $10 | $10 |
| Operating Income | -$15 | -$17 | -$11 | -$10 |
| % Margin | – | -4,731% | – | -1,635.9% |
| Other Income/Exp. Net | -$1 | $4 | -$3 | -$2 |
| Pre-Tax Income | -$16 | -$14 | -$14 | -$12 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16 | -$14 | -$14 | -$12 |
| % Margin | – | -3,765.8% | – | -1,880.6% |
| EPS | -0.5 | -0.61 | -0.47 | -0.4 |
| % Growth | 18% | -29.8% | -17.5% | – |
| EPS Diluted | -0.5 | -0.61 | -0.47 | -0.4 |
| Weighted Avg Shares Out | 33 | 22 | 29 | 29 |
| Weighted Avg Shares Out Dil | 33 | 22 | 29 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$16 | -$17 | -$10 | -$10 |
| % Margin | – | -4,618% | – | -1,584.7% |